T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling

被引:49
作者
Deane, Jonathan A.
Kharas, Michael G.
Oak, Jean S.
Stiles, Linda N.
Luo, Ji
Moore, Travis I.
Ji, Hong
Rommel, Christian
Cantley, Lewis C.
Lane, Thomas E.
Fruman, David A.
机构
[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
[2] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA
[4] Serono Pharmaceut Res Inst, Geneva, Switzerland
[5] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92717 USA
关键词
D O I
10.1182/blood-2006-07-038620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The class IA subgroup of phosphoinositide 3-kinase (PI3K) is activated downstream of antigen receptors, costimulatory molecules, and cytokine receptors on lymphocytes. Targeted deletion of individual genes for class IA regulatory subunits severely impairs the development and function of B cells but not T cells. Here we analyze conditional mutant mice in which thymocytes and T cells lack the major class IA regulatory subunits p85 alpha, p55 alpha, p50 alpha, and p85 beta. These cells exhibit nearly complete loss of PI3K signaling downstream of the T-cell receptor (TCR) and CD28. Nevertheless, T-cell development is largely unperturbed, and peripheral T cells show only partial impairments in proliferation and cytokine production in vitro. Both genetic and pharmacologic experiments suggest that class IA PI3K signaling plays a limited role in T-cell proliferation driven by TCR/CD28 clustering. In vivo, class IA-deficient T cells provide reduced help to B cells but show normal ability to mediate antiviral immunity. Together these findings provide definitive evidence that class IA PI3K regulatory subunits are essential for a subset of T-cell functions while challenging the notion that this signaling mechanism is a critical mediator of costimulatory signals downstream of CD28.
引用
收藏
页码:2894 / 2902
页数:9
相关论文
共 63 条
  • [1] AagaardTillery KM, 1996, J IMMUNOL, V156, P4543
  • [2] AagaardTillery KM, 1996, J IMMUNOL, V157, P2769
  • [3] Essential role for the p110δ phosphoinositide 3-kinase in the allergic response
    Ali, K
    Bilancio, A
    Thomas, M
    Pearce, W
    Gilfillan, AM
    Tkaczyk, C
    Kuehn, N
    Gray, A
    Giddings, J
    Peskett, E
    Fox, R
    Bruce, I
    Walker, C
    Sawyer, C
    Okkenhaug, K
    Finan, P
    Vanhaesebroeck, B
    [J]. NATURE, 2004, 431 (7011) : 1007 - 1011
  • [4] Bergmann CC, 1999, J IMMUNOL, V163, P3379
  • [5] Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase
    Bi, L
    Okabe, I
    Bernard, DJ
    Wynshaw-Boris, A
    Nussbaum, RL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) : 10963 - 10968
  • [6] Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase
    Bi, L
    Okabe, I
    Bernard, DJ
    Nussbaum, RL
    [J]. MAMMALIAN GENOME, 2002, 13 (03) : 169 - 172
  • [7] Borlado LR, 2000, FASEB J, V14, P895
  • [8] Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement
    Brachmann, SA
    Yballe, CA
    Innocenti, M
    Deane, JA
    Fruman, DA
    Thomas, SM
    Cantley, LC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (07) : 2593 - 2606
  • [9] Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002
    Brunn, GJ
    Williams, J
    Sabers, C
    Wiederrecht, G
    Lawrence, JC
    Abraham, RT
    [J]. EMBO JOURNAL, 1996, 15 (19) : 5256 - 5267
  • [10] Cutting edge:: Distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL
    Burr, JS
    Savage, NDL
    Messah, GE
    Kimzey, SL
    Shaw, AS
    Arch, RH
    Green, JM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (09) : 5331 - 5335